Invest in Neumomed
An ongoing revolution in therapeutic care to improve the lives of millions of patients with respiratory diseases.
Our innovative solutions, driven by advanced technology and cutting-edge medical expertise, are addressing some of the most critical challenges facing healthcare systems today.
The Healthcare System Problem
With limited resources and increasing demand, healthcare providers struggle to deliver effective care to a growing number of patients, especially those with chronic conditions.
These conditions strain healthcare capacity, leading to inadequate care and higher costs. In many cases, healthcare providers lack the resources and infrastructure to offer long-term, personalized treatment plans that improve patient outcomes.
Resumir
Why Neumomed Corp?
At Neumomed Corp, we are changing the way healthcare systems approach chronic conditions by leveraging our innovative STM platform. Our solution addresses the gaps in capacity, reach, and patient adherence, allowing healthcare providers to:
Scale capacity
Through our AI-powered platform, healthcare teams can manage a larger population of patients without increasing staff or infrastructure.
Extend reach
The digital nature of our therapeutic model means that patients in remote areas or underserved communities can access high-quality care without the need for in-person visits.
Improve adherence
Our therapeutic model incorporates Cognitive Behavioral Therapy (CBT), mindfulness, and other behavioral techniques that significantly improve treatment adherence, reducing hospitalizations and improving quality of life.
NeumoMed – Transforming Therapeutic Care
At NeumoMed, we are revolutionizing healthcare by integrating cutting-edge AI-driven therapeutic models with expert care. Our focus is on addressing chronic respiratory diseases, sleep disorders, and smoking cessation, enabling healthcare providers and insurers to deliver effective and personalized care to their patients at scale.
Proven Expertise Backed by Experience
NeumoMed is powered by 14 years of experience through our operations in NeumoMed Colombia, where we’ve served over 40,000 patients. Our extensive partnerships with top healthcare institutions across Colombia underscore our credibility and strong track record of success. Now, we’re bringing that same innovation to new markets.
Cambiar orden (poner después del problema)
Our Solution: Revolutionizing Therapeutic Care
We are transforming therapeutic care to enhance the well-being of millions affected by respiratory diseases. Our innovative solution boosts healthcare capacity with specialized programs and treatments, focusing on pivotal issues like respiratory disorders, sleep apnea therapy (TMO), smoking and vaping cessation, and promoting healthy sleep.
Key Components of Our Solution
Expanded Capacity through Programs and Therapies
- Respiratory Program
- Sleep Apnea Therapy (TMO)
- Smoking and Vaping Cessation Program
- Healthy Sleep Program
Sustituir por el Home
Scientific Team
- Dr. Claudia Diaz, Pulmonology Specialist and Vice President of the Colombian Association of Pulmonology and Thoracic Surgery.
- Dr. Eliana Rivera, PhD in Speech Therapy.
- Supported by 120 health professionals specializing in various fields to deliver high-quality care.
Quitar nombres y poner que el equipo científico diseñó las terapias y programas.
Technological Platform
- NeumoMed Corp’s Smart Therapy Management (STM) platform integrates generative AI, enabling doctors to efficiently manage larger patient populations, enhance interaction, and increase patient adherence through personalized care.
Help Desk Support
- The STM help desk offers 24/7 technical support to healthcare providers, ensuring seamless therapy management and rapid resolution of any issues that may arise.
Our team
At NeumoMed, we are led by a dynamic and experienced team that combines expertise in medicine, technology, and business to revolutionize therapeutic care on a global scale.
Dr. Claudia Díaz, MD
Chief Medical Officer and Co-Founder
Dr. Claudia Díaz is a specialist in Internal Medicine and Pulmonology, and the Vice President of the Colombian Society of Pulmonology and Thoracic Surgery. She has over 15 years of experience in respiratory health and sleep disorders and is instrumental in driving innovation in NeumoMed's therapeutic programs. Her leadership in medical research and treatment protocols ensures that NeumoMed’s solutions meet the highest medical standards.
Juan Carlos Salas
CEO and Co-Founder
Juan Carlos Salas, an expert in engineering and business development, holds a degree in Electronic and Telecommunications Engineering, along with an MBA focused on sustainability. With extensive experience in the integration of AI-driven solutions, Juan Carlos leads NeumoMed’s strategic vision and has played a critical role in developing the Smart Therapy Management (STM) platform. His leadership ensures seamless integration of technology and healthcare.
Juan Carlos Junca
Director and Financial Advisor
With a robust background in entrepreneurship, management consulting, and strategic partnerships, Juan Carlos Junca drives NeumoMed’s expansion efforts across new regions. His expertise lies in business development and his ability to create strategic alliances that propel the company into new markets like Peru, Mexico, and South Florida.
Tito Yepes
Director and Strategic Advisor.
Tito Yepes brings a wealth of experience in economic analysis, financial modeling, and investment strategies. With a solid foundation in finance and economics, Tito ensures that NeumoMed’s financial health is aligned with its growth objectives. His stewardship in resource allocation, investor relations, and financial planning supports the company's long-term sustainability.
Felipe Salazar
Business Expansion Director
Felipe Salazar is an expert in retail management and wholesale distribution, with a strong track record of leading companies to operational excellence. His MBA in Business Administration and experience in scaling businesses equip him to lead NeumoMed's efforts in growing its global footprint, particularly in Latin America and the U.S.
Strategic Partnerships & Market Expansion
Our success in Colombia paves the way for strategic partnerships with healthcare providers and insurers globally. By working together, we can help solve the capacity challenges facing modern healthcare systems, increasing access to critical therapies for respiratory diseases and sleep disorders while reducing operational costs.
Why Partner with NeumoMed?
Proven Results
Over 40,000 patients served with high adherence rates across our programs.Innovative Solutions
Advanced AI-powered STM platform that enhances the effectiveness of therapies.Cost Reduction
Clients benefit from significant cost reductions, including a 60% decrease in healthcare costs for high-risk patients, and a 40% reduction in sleep apnea treatment costs.Scalability
Our model is designed to seamlessly expand across diverse healthcare systems, offering substantial benefits to healthcare providers and insurers alike.Report and Results
To maintain transparency and build trust with our stakeholders, we publish comprehensive reports on our financial and operational performance. These reports are designed to provide investors with clear insights into our growth, milestones, and impact. Stay informed with our regular updates:
-
Quarterly and Annual Reports
-
Performance Summaries
-
Strategic Milestones
Interested in Investing?
If you are interested in learning more about investment opportunities with NeumoMed, please leave your contact details. We will send you our Pitch Deck, financial reports, and business plan to help you make an informed decision.
Looking to the Future
Our vision is clear: to expand our solutions to key markets in Latin America and the USA, transforming the way healthcare is delivered by leveraging technology to meet growing demands. By partnering with NeumoMed, you’re not just investing in a company—you’re investing in the future of healthcare.
Market Opportunity: Unlocking a Global Healthcare Revolution
The global healthcare industry is at a turning point. Respiratory diseases, sleep disorders, and the rising demand for smoking cessation programs represent some of the most urgent health challenges worldwide. Currently, over 1.5 billion people are affected by these conditions, putting enormous pressure on healthcare systems that lack the capacity to manage this growing demand.
NeumoMed Corp is addressing this gap with an AI-driven therapeutic model that enhances the capacity of insurers and healthcare providers to deliver high-quality care at scale. Our solution is already making a significant impact in Colombia, where we’ve partnered with the top health insurer and treated over 30,000 patients with respiratory and sleep disorders, as well as smoking cessation.
-
1.5 billion people globally are smokers or vapers
creating a critical demand for cessation therapies.
-
COPD and Asthma affect over 670 million people
creating long-term opportunities for healthcare providers to improve outcomes and reduce hospitalizations.
-
Sleep disorders impact nearly 4 billion people
and current solutions are limited in reach and effectiveness.
With NeumoMed's integrated Therapeutic Model, we empower healthcare systems to scale their services, reaching more patients and delivering cost-effective care that improves patient outcomes.
Financial Projections: Scaling a Proven Model
Our proven business model is subscription-based, generating recurring monthly revenue through partnerships with healthcare providers and insurers. In 2023, NeumoMed generated over $2 million in revenue in Colombia alone, with significant potential to expand into new markets.
As we project our future growth, we are focused on scaling our model to new regions, including Peru, Mexico, and South Florida. With these expansions, we expect to:
-
Increase our patient base to 9.000 over the next two years.
-
Achieve annual revenues exceeding $2.5 million in two years.
-
Secure new partnerships with major insurers and healthcare providers in emerging markets.
NeumoMed is seeking $2 million in funding to execute this first phase of expansion. These resources will be directed towards:
- Technology Development: Enhancing our AI-powered platform and scaling it for global use.
- Operational Expansion: Building teams in Peru, Mexico, and Florida to oversee local operations.
- Strategic Partnerships: Establishing new relationships with key healthcare stakeholders to ensure rapid adoption of our solution.
A Growing, High-Potential Market
-
Global Respiratory Market projected to reach $43 billion by 2026.
-
Smoking Cessation Market valued at $64 billion by 2027.
-
The growing demand for sleep disorder treatments represents a significant untapped market with long-term potential.
NeumoMed is at the forefront of this healthcare revolution, offering a scalable, effective solution that addresses both capacity and adherence challenges faced by current healthcare systems.
Technology and Innovation
At NeumoMed Corp, innovation is at the heart of everything we do. Our Smart Therapy Management (STM) platform integrates cutting-edge technology with medical expertise to address the global health challenges of respiratory diseases, smoking cessation, and sleep disorders. Here's how our Therapeutic Model stands out:
Generative AI for Patient Care
STM leverages AI to optimize the management of large patient populations. By automating routine tasks and enhancing patient interaction through natural language processing, doctors can focus on personalized care for each patient, improving treatment adherence and outcomes.
Multimodal Therapeutic Approach
Our model combines Cognitive Behavioral Therapy (CBT), mindfulness techniques, and Tiny Habits to create tailored programs for each patient, increasing the likelihood of successful therapy and long-term health improvements.
Seamless Integration with Healthcare Providers
The STM platform is designed to complement the existing healthcare infrastructure. It integrates with the systems of insurers and healthcare providers to maximize their capacity to deliver effective care to a larger population.
Scalable Across Markets
Our Therapeutic Model flexibility allows it to be adapted across different countries and healthcare systems, making it an ideal solution for emerging markets where healthcare resources are limited.
Investor Opportunity
As we continue to revolutionize therapeutic care, NeumoMed Corp offers a unique investment opportunity in a rapidly growing global health sector. The rise of respiratory diseases, sleep disorders, and addictions like smoking and vaping have created an urgent need for scalable, effective solutions that reduce healthcare costs and improve patient outcomes. Our advanced STM platform and integrated therapeutic models are already proving effective, with significant traction in Colombia and plans for expansion into Peru, Mexico, and the U.S.
Why Invest in NeumoMed Corp?
Proven Success
Our innovative solutions have already generated $2 million in revenue within the past year, and we have successfully treated more than 30,000 patients with our therapies and programs.
Scalable Model
With a Therapeutic Model designed for global reach, we are poised for significant expansion, starting with Latin America and the U.S.
Strong Partnerships
We have established partnerships with key healthcare providers and insurance companies, ensuring a broad market entry.
High-Impact Market
In our first phase of expansion, we project revenues exceeding USD 2.5 million by 2026. Following this, we will initiate our second phase of growth, leveraging our established success to continue expanding into new markets and scaling our solution.
By investing in NeumoMed Corp, you will join us in shaping the future of therapeutic healthcare, leveraging advanced technology to improve lives on a global scale.
Our Company
At NeumoMED, we are committed to revolutionizing therapeutic care for patients with respiratory diseases. Our mission is to enhance the quality of life for millions by delivering innovative and effective treatment solutions. Through cutting-edge research and dedicated patient care, we strive to lead the way in respiratory health. Our team of experts is passionate about making a tangible difference in the lives of those we serve. Join us on our journey to breathe new life into respiratory care.